Meta description: This regulatory update reports on a Cairo University trial evaluating a fat cavitation device for lipedema adipose thickness. Published February 11, 2026. The ClinicalTrials.gov listing identifies lipedema as the condition and fat cavitation as the device intervention with Cairo University as sponsor. The study is listed as available and represents a device based approach to assessing adipose tissue in lipedema. This update is relevant to regulators, device developers and clinicians monitoring lipedema care.
News summary: On 11 February 2026, ClinicalTrials.gov published a record indicating a study sponsored by Cairo University to assess a fat cavitation device in lipedema patients. The entry shows lipedema as the condition and lists fat cavitation as the intervention. The sponsor and availability status are clearly stated. The listing signals a device oriented non pharmacologic method for measuring and potentially influencing adipose tissue thickness in lipedema.
The following sections provide the key facts and regulatory context. In line with common industry practice, readers should look for trial updates such as enrollment status and results on adipose tissue thickness. Official data comes from the ClinicalTrials.gov entry linked below.
What is being studied?
The ClinicalTrials.gov record NCT07404059 identifies lipedema as the condition and lists a device described as fat cavitation as the intervention. The sponsor is Cairo University. The listing notes that the study is available and that the primary outcome involves changes in adipose tissue thickness in participants with lipedema. No results are reported in the current record, which is typical for a trial in the early stage of data collection.
What device and approach are described?
The intervention is a fat cavitation device. The record provides no further device specifications or operational parameters in the available text. The emphasis is on measuring adipose tissue thickness, not on therapeutic claims at this stage.
What is the regulatory context for this study?
The entry presents a university sponsored device trial focused on a non pharmacologic approach to adipose tissue assessment in lipedema. It aligns with the general expectation that device based trials disclose condition, intervention and outcome goals while deferring safety and efficacy conclusions until results are available. The text is written to support transparency and governance but it does not imply regulatory approval or labeling decisions.
What should readers watch for?
Observers should track trial status updates, any safety signals and eventual results on adipose tissue thickness. Positive or negative results could influence subsequent regulatory discussions and potential labeling considerations for a fat cavitation device. Until final data are published, the entry remains an informational record that supports monitoring of device oriented approaches in lipedema management.
Where to access information about the trial?
The official record is available on ClinicalTrials.gov. The page identifies lipedema as the condition, lists fat cavitation as the intervention and shows Cairo University as the sponsor. Professionals should refer to the record for current status and future updates. The link provided below directs to the trial page.
FAQ
- What condition is studied Lipedema is the focus of the trial.
- What intervention is used A device described as fat cavitation is listed as the intervention.
- Where can more information be found The official ClinicalTrials.gov record NCT07404059 is provided via the link below.
Conclusion and implications
The listing confirms a device oriented study aimed at assessing adipose tissue thickness in lipedema. It does not provide results and does not imply regulatory approval. Ongoing updates will inform regulatory and clinical stakeholders on potential pathways for device based lipedema management and for future labeling decisions if data support safety and performance claims.
Disclaimer for professionals
This article is intended for regulatory and clinical professionals and is not legal advice. It summarizes a trial listing based on the source text and does not replace regulatory guidance or formal determinations by authorities.
https://clinicaltrials.gov/study/NCT07404059?term=medical+device